As of May 14, 2026, the three largest insider holders of EOLS are Inc. Medytox (Other, 3.38Mn shares), Vikram Malik (Director, 1.14Mn shares), David Moatazedi (Director, 604.70K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Inc. Medytox | - | 3,381,326 | 0 | 18 Oct, 2023 |
| Vikram Malik | - | 0 | 1,143,701 | 25 Aug, 2021 |
| David Moatazedi | - | 604,700 | 0 | 20 Mar, 2026 |
| Simone Blank | - | 0 | 482,783 | 15 Aug, 2023 |
| Rui Avelar | - | 427,423 | 0 | 20 Mar, 2026 |
| Vikram Malik | - | 321,109 | 0 | 19 Feb, 2026 |
| Tatjana Mitchell | Chief Financial Officer | 226,092 | 0 | 19 Feb, 2026 |
| Sandra Beaver | Chief Financial Officer | 167,089 | 0 | 14 May, 2025 |
| Lauren P Silvernail | - | 141,571 | 0 | 18 May, 2022 |
| Crystal Muilenburg | Chief Marketing Officer | 134,248 | 0 | 10 Mar, 2022 |
| Brady Stewart | - | 134,188 | 0 | 19 Feb, 2026 |
| Albert G Iii White | - | 95,937 | 0 | 19 Feb, 2026 |
| Tomoko Yamagishi-Dressler | Chief Marketing Officer | 89,949 | 0 | 26 Aug, 2025 |
| Simone Blank | - | 77,111 | 0 | 11 Mar, 2025 |
| Robert Hayman | - | 54,856 | 0 | 09 Feb, 2024 |
| Robert Hayman | - | 0 | 10,366 | 15 Aug, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Mar, 2026 | David Moatazedi | Common Stock | D | 13,669 | $4.75 | 604,700 | D | S |
| 20 Mar, 2026 | Rui Avelar | Common Stock | D | 3,119 | $4.75 | 427,423 | D | S |
| 16 Mar, 2026 | Rui Avelar | Common Stock | A | 8,804 | $0.00 | 460,538 | D | M |
| 16 Mar, 2026 | David Moatazedi | Common Stock | A | 67,489 | $0.00 | 735,089 | D | M |
| 17 Mar, 2026 | David Moatazedi | Common Stock | D | 116,720 | $4.89 | 618,369 | D | S |
| 17 Mar, 2026 | Rui Avelar | Common Stock | D | 29,996 | $4.89 | 430,542 | D | S |
| 16 Mar, 2026 | Rui Avelar | Performance Restricted Stock Units | D | 8,804 | $0.00 | 8,802 | D | M |
| 16 Mar, 2026 | David Moatazedi | Performance Restricted Stock Units | D | 67,489 | $0.00 | 67,488 | D | M |
| 17 Feb, 2026 | Rui Avelar | Common Stock | A | 94,913 | $0.00 | 451,734 | D | A |
| 17 Feb, 2026 | David N Gill | Common Stock | A | 45,559 | $0.00 | 86,887 | D | A |
| 17 Feb, 2026 | Albert G Iii White | Common Stock | A | 45,559 | $0.00 | 95,937 | D | A |
| 17 Feb, 2026 | Brady Stewart | Common Stock | A | 45,559 | $0.00 | 134,188 | D | A |
| 17 Feb, 2026 | Tatjana Mitchell | Common Stock | A | 121,489 | $0.00 | 226,092 | D | A |
| 17 Feb, 2026 | Vikram Malik | Common Stock | A | 45,559 | $0.00 | 321,109 | D | A |
| 17 Feb, 2026 | David Moatazedi | Common Stock | A | 313,212 | $0.00 | 667,600 | D | A |
| 17 Feb, 2026 | Tatjana Mitchell | Performance Restricted Stock Units | A | 121,489 | $0.00 | 121,489 | D | A |
| 17 Feb, 2026 | David Moatazedi | Performance Restricted Stock Units | A | 626,424 | $0.00 | 626,424 | D | A |
| 17 Feb, 2026 | Rui Avelar | Performance Restricted Stock Units | A | 94,913 | $0.00 | 94,913 | D | A |
| 17 Feb, 2026 | Rui Avelar | Stock Option (Right to Buy) | A | 138,649 | $0.00 | 138,649 | D | A |
| 17 Feb, 2026 | David Moatazedi | Stock Option (Right to Buy) | A | 457,541 | $0.00 | 457,541 | D | A |